Pharmaceutical Price Transparency: Structural Shifts in Outcomes and Provider Incentives
The 2025 federal pricing transparency rule forces manufacturers to disclose net prices and price‑justification narratives, compressing margins and reshaping prescribing incentives, while…

































































































